Brevan Howard Capital Management’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-11,093	Closed	-$89.4K	–	1382
2024 Q3	$89.4K	Sell	11,093 -18,572	-63%	-$150K	﹤0.01%	1021
2024 Q2	$252K	Buy	29,665 +5,058	+21%	+$42.9K	﹤0.01%	778
2024 Q1	$221K	Sell	24,607 -661	-3%	-$5.93K	﹤0.01%	719
2023 Q4	$284K	Buy	+25,268	New	+$284K	﹤0.01%	694